pharmacokenetic 3 Flashcards

1
Q

what is TDM?

A

Therapeutic drug monitoring (TDM) is the practice of using drug levels, p/kinetics and p/dynamics to optimise drug therapy to individual patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is TDM used for?

A

Drugs with a narrow therapeutic rangeor low therapeutic index
Drugs where dose and effect are not strongly correlated
Drugs with wide inter-patient variation in clearance – theophylline
Drugs with toxicity that is not necessarily evidenced by easily observable symptoms – Gentamicin
Monitoring compliance
Confirming toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the equation for TI?

A

T.I = TD50/ED50

t= toxic
e= effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

when is cp used in practice

A

Cp should ideally be at steady state
Remember time to SS is about five times t1/2
From the point the patient starts taking the drug

Remember that analytical methods will (most likely) return TOTAL Cp levels, with no distinction between bound and unbound drug (chromatography)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

explain protein binding (TDM)

A

In the Plasma there is many soluble proteins
drug which Free in solution
Drug is bound to water soluable – not free to act
Does not differentiate between bound and unbound In analaytic methods
they are at equilibrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Drug interactions with a weakly bound drug

A

Imagine a drug ‘A’ thatis 5% protein bound
A second drug ‘B’ is introduced
It displaces bound drugfrom the protein, increasing the free level by 3%
The free (active) drug level changes from 95% to 98%
This is a negligible 1.03 times increase:and so it is unlikely to cause a patient any problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Drug interactions with a strongly bound drug

A

Imagine a drug ‘A’ thatis 95% protein bound
A second drug ‘B’ is introduced
It displaces bound drugfrom the protein, increasing the free level by 3%
The free (active) drug level changes from 5% to 8%
This is a massive 1.6 times increase:and so it is highly likely to cause a patient a problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Saturation of protein binding

A

Valproic acid is ~90% bound to albumin up to Cp  75g/ml
Above this Cp, the protein binding sites are saturated and an increased dose brings about a disproportionate rise in the free fraction of valproic acid
Therapeutic effectwill rise in line with Cp(free)and may well causeproblems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Individuals vs. populations values

A

In TDM, we use population values as a starting point and then ‘tweak’ them to suit individuals

Use population values to start patient dosing
Once at steady state, measure patient Cp
Compare with expected Cp from population values
Adjust clearance to better represent the actual drug clearance in this patient, such that calculated Cp is in better agreement with observed Cp
Proceed using the “patient-specific” clearance in future calculations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

General principles of TDM

A

-Information gathering
Patient’s physical details, clinical / biochemical status
Drug history, dosage regimes
Pharmacokinetic data (e.g. Vd and t1/2) for relevant drugs
Any prior pharmacokinetic information for the patient [may or may not be available, depending upon history]
Take blood and measure Cp
Work out what Cp ought to be using population values
Adjust clearance until you get good agreement

-If individual does not match population, check
concurrent drug therapy
compliance
medication error
mal-absorption
incorrect assay results
complete distribution, equilibrium Cp ?
laboratory error? e.g. incorrect sample storage
-Patient kinetics may simply deviate significantly from population kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Can we get a handle on likely clearance in advance of starting therapy

A

Rather than wait until steady state to find out that a patient has lower (or higher) than expected clearance…
…We can assess their likely clearance from a SINGLE blood sample taken before they start treatment
This is known as estimating their creatinine clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is creatinine

A

Creatinine is a breakdown product of creatine phosphate in muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Useful properties of creatinine

A

Creatinine is usually produced at a constant rate
It is not protein bound
It is filtered by the kidneys with little or no reabsorption
Accordingly, creatinine clearance is a good indication of patient renal function
Creatinine clearance approximates the actual glomerular filtration rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Measuring creatinine clearance (equation)
dont need to memorise

A

clcr= c urine * v urine / c plasma

C urine is the creatinine concentration in the urine in mg / mL
V urine is the volume of urine collected in mL / min
C plasma is the creatinine concentration in the plasma in mg / mL

So creatinine clearance is measured in mL / minute, as expected, because clearance has units of volume per time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

equation for Estimating creatinine clearance

A

crcl est = (140-age) * weight * constant /cs

Constant is 1.23 for men, 1.04 for women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Creatinine in renal impairment
mild
mod
severe

A

BNF
Mild
gfr 20-50
serum creatnine 150-300

Moderate
10-20
300-700

Severe
< 10
> 700

17
Q

Which drugs for TDM?

A

Antiepileptics
e.g. Phenytoin, carbamazepine, valproic acid / sodium valproate,

phenobarbitone
e.g. lamotrigine, vigabatrin, gabapentin, tiagabine, topiramiate

Aminoglycoside antibiotics
e.g. Gentamicin, tobramicin, amikacin

Cardiac
e.g. Digoxin, lidocaine, flecainide, procainamide

Others
Theophylline, lithium, methotrexate, ciclosporin